Eli Lilly has announced a strategic collaboration with UK government departments to address population health challenges, ...

TenNor Therapeutics has raised over 300 million yuan ($41 million) in a series E round, led by AMR Action Fund, to advance ...

A staggering 800% increase in licensing agreement deal values for messenger ribonucleic acid (mRNA)-based innovator ...

Chinese biopharma Hutchmed (LON: HCM) was trading 5% higher at the mid-point of London’s trading day on Wednesday. The ...

TRIANA Biomedicines has entered into a strategic collaboration and licensing agreement with US pharma giant Pfizer to ...

Eli Lilly (NYSE: LLY) has partnered with the UK government, investing £279 million ($340 million) to address public health ...

Nuclera has raised $75 million, led by Elevage Medical Technologies, to commercialize its eProtein Discovery system. The ...

The US Food and Drug Administration (FDA) has approved Novocure's Optune Lua for concurrent use with PD-1/PD-L1 inhibitors or ...

UK pharma major GSK has sued USA-based Moderna this week, accusing the latter of violating patents protecting GSK’s COVID-19 ...

Johnson & Johnson has announced positive Phase II/III trial results for nipocalimab in generalized myasthenia gravis (gMG). The drug showed significant IgG reduction and sustained disease control.

Polish clinical-stage biotech Molecure has signed an exclusive licensing agreement with Ocean Biomedical based in Providence, ...

Amgen has reported positive Phase III results for Uplinza (inebilizumab-cdon) in treating generalized myasthenia gravis (gMG) ...